Seattle Genetics, Inc. today announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant showing that the median overall survival …
Nature：AMPK酶在癌症中的双重作用 – 生物谷 (新闻发布)
生物谷 (新闻发布)Nature：AMPK酶在癌症中的双重作用生物谷 (新闻发布)趋化因子及受体CCL5/CCR5促进乳腺癌转移 · Cancer Res：蛋白质RAL与肿瘤的侵袭性特征有关 · J Biol Chem：方靖等揭示FOX…
Scientists grow new vein from girl's stem cell – Business Standard
Scientists grow new vein from girl's stem cellBusiness StandardFor the first time, scientists led by an Indian-origin researcher have successfully replaced a major blood vessel in a 10-year-old girl with a vein grown in a lab using her own stem cel…
@IU_Health draws big audience for transplant
As two Sullivan County men went through a life-saving kidney transplant on Wednesday, a worldwide audience checked in online to follow the progress of the surgery and ask questions of the medical team via Indiana’s first “Twittercast” of a live s…
Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or r…
'So I’m living for today'
Seven years ago, Justine Laymond lay on a hospital bed on life-support. After a double lung transplant, the 39-year-old British woman is a crew member on Edinburgh Inspiring Capital, the Scottish entrant in the Clipper Round the World Yacht Race. (CHRI…
Voluntary blood donation need of the hour – The Hindu
Zee NewsVoluntary blood donation need of the hourThe HinduLack of idea on medical and health benefits of donating blood or non-dissemination of knowledge on absence of any side effects in a healthy eligible male, …City people still hesitate in blood …
Aspirin vs warfarin: which is better? – Selby Times
Aspirin vs warfarin: which is better?Selby TimesHeart failure occurs when the heart can't pump enough blood around the body to … During the study, 2305 people with heart failure but no clear need to take …and more »
Millennium Highlights Updated Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Patients with …
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or …
Cell Therapeutics Appoints New Chief Medical Officer – Business Review India (press release)
Cell Therapeutics Appoints New Chief Medical OfficerBusiness Review India (press release)The EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controlled phase 3 clinical trial…